These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 28046032)
1. Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide. Laube M; Amann E; Uhlig U; Yang Y; Fuchs HW; Zemlin M; Mercier JC; Maier RF; Hummler HD; Uhlig S; Thome UH PLoS One; 2017; 12(1):e0169352. PubMed ID: 28046032 [TBL] [Abstract][Full Text] [Related]
2. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia. Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Permissive Hypercapnia. Gentner S; Laube M; Uhlig U; Yang Y; Fuchs HW; Dreyhaupt J; Hummler HD; Uhlig S; Thome UH Front Pediatr; 2017; 5():246. PubMed ID: 29209598 [TBL] [Abstract][Full Text] [Related]
4. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Munshi UK; Niu JO; Siddiq MM; Parton LA Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Truog WE; Ballard PL; Norberg M; Golombek S; Savani RC; Merrill JD; Parton LA; Cnaan A; Luan X; Ballard RA; Pediatrics; 2007 Apr; 119(4):670-8. PubMed ID: 17403837 [TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Mercier JC; Hummler H; Durrmeyer X; Sanchez-Luna M; Carnielli V; Field D; Greenough A; Van Overmeire B; Jonsson B; Hallman M; Baldassarre J; Lancet; 2010 Jul; 376(9738):346-54. PubMed ID: 20655106 [TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide for respiratory failure in preterm infants. Barrington KJ; Finer N Cochrane Database Syst Rev; 2010 Dec; (12):CD000509. PubMed ID: 21154346 [TBL] [Abstract][Full Text] [Related]
8. Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. Gupta GK; Cole CH; Abbasi S; Demissie S; Njinimbam C; Nielsen HC; Colton T; Frantz ID Pediatr Pulmonol; 2000 Oct; 30(4):275-81. PubMed ID: 11015126 [TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide for respiratory failure in preterm infants. Soll RF Neonatology; 2012; 102(4):251-3. PubMed ID: 22907671 [TBL] [Abstract][Full Text] [Related]
11. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia. Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203 [TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial. Greenough A; Decobert F; Field D; Hallman M; Hummler HD; Jonsson B; Sánchez Luna M; Van Overmeire B; Carnielli VP; Potenziano JL; Mercier JC J Perinat Med; 2020 Sep; 49(1):104-110. PubMed ID: 32892178 [TBL] [Abstract][Full Text] [Related]
13. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. Niu JO; Munshi UK; Siddiq MM; Parton LA J Pediatr; 1998 Jun; 132(6):965-70. PubMed ID: 9627587 [TBL] [Abstract][Full Text] [Related]
14. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia. Aghai ZH; Saslow JG; Mody K; Eydelman R; Bhat V; Stahl G; Pyon K; Bhandari V Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160 [TBL] [Abstract][Full Text] [Related]
15. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. Gadhia MM; Cutter GR; Abman SH; Kinsella JP J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327 [TBL] [Abstract][Full Text] [Related]
16. [Significance of nitric oxide inhalation (NO) in preterm infants< 34 weeks of gestation]. Wirbelauer J; Speer CP Klin Padiatr; 2010 Mar; 222(2):56-61. PubMed ID: 20175046 [TBL] [Abstract][Full Text] [Related]